ITF Therapeutics
The Sr. Manager, Field Reporting & Analytics partners with field and commercial leadership to deliver KPI dashboards, reporting solutions, and sub‑national analytics that inform business decisions across territories and accounts. The role translates complex data into actionable insights, oversees dashboard development and adoption, and supports field account planning with data‑driven recommendations.
Headquarters
Concord, Massachusetts, United States
Company Size
1-10 employees
Founded
2024
ITF Therapeutics LLC is the United States affiliate of Italfarmaco S.p.A., founded in 2024 and based in Concord, MA. The company focuses on bringing therapeutic options to people living with rare diseases, most notably commercializing DUVYZAT (givinostat), an FDA‑approved HDAC inhibitor for Duchenne muscular dystrophy (DMD), in the U.S. market. ITF combines a flexible, entrepreneurial approach with the resources and legacy of its parent organization to deliver treatments, support programs, and educational resources for patients, clinicians, and researchers.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ITF Therapeutics.
36% above the average for this role
Manager, Commercial Analytics & Reporting
Tonix Pharmaceuticals
Director, Field Sales Effectiveness-Analytics
Sanofi
Strategic Analytics and Reporting Specialist
Chimera Enterprises International
Sr Associate, Field Reporting
lifelancer
Associate Director, US Field Analytics
Revolution Medicines
Reporting & Analytics Analyst (L1)
HCL Group